Development and Commercialization of Products. 4.1 Development of Active Compounds or Analogs. ANADYS shall be solely responsible and shall have sole discretion for evaluating the potential for development and commercialization of all Active Compounds or Analogs. In addition, ANADYS has the right to sublicense Active Compounds. ANADYS, its Affiliates or sublicensee, or its subcontractor shall be responsible for conducting all development and evaluations of any Active Compound or Analog and for filing and obtaining government approval of any such Product(s).
Appears in 2 contracts
Sources: Research and License Agreement (Anadys Pharmaceuticals Inc), Research and License Agreement (Anadys Pharmaceuticals Inc)